In April, the U.S. Food and Drug Administration (FDA) approved the commercial distribution of pigs genetically edited with CRISPR technology to resist porcine reproductive and respiratory syndrome (PRRS), a costly and widespread disease in pork production. These pigs are expected to enter the American market in 2026. Yet Canadian consumers could start seeing gene-edited pork products in stores — unlabelled and unannounced — as early as next year.
